Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. Nicholls SJ, Pavo I, Bhatt DL, Buse JB, et al. N Engl J Med 2025;393:2409-2420.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nicholls SJ, Pavo I, Bhatt DL, Buse JB, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. N Engl J Med 2025;393:2409-2420.
PMID: 41406444